The recent $37.76 Million Settlement with CVS for over-dispensing insulin pens is more than just a large fine; it’s a powerful illustration of the government’s primary weapon against healthcare fraud: The False Claims Act (FCA). This case provides a crucial look into the high-stakes legal framework that protects taxpayer-funded programs like Medicare, Medicaid, and TRICARE. What Law Was Broken? The False Claims Act (FCA) The core of the CVS settlement is a violation of the Federal False Claims Act (31 U.S.C. §§ 3729-3733). This is the government’s most effective tool for recovering funds lost due to fraud. 1. The Core Violation: A "False Claim" The FCA targets anyone who knowingly submits, or causes to be submitted, a false or fraudulent claim for payment to the U.S. government. This law targets anyone who knowingly submits, or causes to be submitted, a false or fraudulent claim for payment to the U.S. government. In the CVS case, the false claims were rooted in t...